We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
International Growth Drives Halliburton (HAL) Q2 Earnings
Read MoreHide Full Article
Oil service bellwether Halliburton Company (HAL - Free Report) reported higher-than-expected second quarter profit on robust international activity. The world's second-largest oilfield services company after Schlumberger (SLB - Free Report) saw its adjusted net income (excluding impairments and other charges) come in at 35 cents per share, outperforming the Zacks Consensus Estimate of 30 cents.
However, the bottom line was below the adjusted earnings of 58 cents in the year-earlier quarter on weakness in the North American market. Operatingincome reported by Halliburton was $303 million, well below the $789 million for the same period last year.
Meanwhile, revenues of $5.9 billion were 3.5% lower than the year-ago quarter and missed the Zacks Consensus Estimate by a marginal 0.6%. North American revenue fell 13.2% year over year to $3.3 billion. Revenue from Halliburton’s international operations rose 12.5% from the year-ago period to $2.6 billion, an area that continues to exhibit growth momentum.
Halliburton Company Price, Consensus and EPS Surprise
The world’s biggest provider of hydraulic fracking noted that United States land activity levels in the second quarter improved sequentially, particularly in the pressure pumping business, while drilling and artificial lift activity picked up too. Halliburton did encounter lower pressure pumping activity in Canada and a fall in drilling fluid activity in the Gulf of Mexico but the company continues to successfully ride the changing market dynamics through excellent execution and management of the controllable factors.
Meanwhile, Halliburton is witnessing broad-based, steady recovery in its international business. The company anticipates its international revenue to grow at a high single-digit rate in 2019, with further improvement next year. Importantly, Halliburton believes it has got the scale and required technology portfolio to take advantage of this growth trend.
Segmental Performance
Operating income from the Completion and Production segment was $470 million, 29.7% below the year-ago level of $669 million. The division’s performance was affected by decline in Latin America stimulation services.
However, the segment operating income bettered our consensus estimate of $430 million. The outperformance was largely the result of strong domestic artificial lift activity, increased cementing job and completion tool sales outside North America, higher stimulation activity in North America and Middle East/Asia, and increased pipeline services throughout Europe/Africa/CIS.
Meanwhile, Drilling and Evaluation unit profit fell from $191 million in the second quarter of 2018 to $145 million in the corresponding period of 2019. The segment income was also below the Zacks Consensus Estimate of $148 million.
The underperformance was on account of lower drilling fluids activity in Latin America and North America, together with decline in software sales. These setbacks were partly offset by stronger project management activity in Middle East/Asia, improved wireline activity globally and increase in North America, Latin America and Europe/Africa/CIS drilling activity.
Balance Sheet
Halliburton’s capital expenditure in the second quarter was $408 million. As of Jun 30, 2019, the Zacks Rank #4 (Sell) company had approximately $1.2 billion in cash/cash equivalents and $10.3 billion in long-term debt, representing a debt-to-capitalization ratio of 52%.
Halliburton currently carries a Zacks Rank #4 (Sell). Meanwhile, investors interested in the oilfield services space could look at some better options like Helix Energy Solutions Group, Inc. (HLX - Free Report) and Oceaneering International, Inc. (OII - Free Report) that sport a Zacks Rank #1 (Strong Buy).
The 2019 Zacks Consensus Estimate for Houston, TX-based Helix Energy Solutions Group is 30 cents, representing some 57.9% earnings per share growth over 2018. Next year’s average forecast is 39 cents pointing to another 27.8% growth.
Oceaneering International has a 100% track of outperforming estimates over the last four quarters at an average rate of 50%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
International Growth Drives Halliburton (HAL) Q2 Earnings
Oil service bellwether Halliburton Company (HAL - Free Report) reported higher-than-expected second quarter profit on robust international activity. The world's second-largest oilfield services company after Schlumberger (SLB - Free Report) saw its adjusted net income (excluding impairments and other charges) come in at 35 cents per share, outperforming the Zacks Consensus Estimate of 30 cents.
However, the bottom line was below the adjusted earnings of 58 cents in the year-earlier quarter on weakness in the North American market. Operatingincome reported by Halliburton was $303 million, well below the $789 million for the same period last year.
Meanwhile, revenues of $5.9 billion were 3.5% lower than the year-ago quarter and missed the Zacks Consensus Estimate by a marginal 0.6%. North American revenue fell 13.2% year over year to $3.3 billion. Revenue from Halliburton’s international operations rose 12.5% from the year-ago period to $2.6 billion, an area that continues to exhibit growth momentum.
Halliburton Company Price, Consensus and EPS Surprise
Halliburton Company price-consensus-eps-surprise-chart | Halliburton Company Quote
Management’s Outlook
The world’s biggest provider of hydraulic fracking noted that United States land activity levels in the second quarter improved sequentially, particularly in the pressure pumping business, while drilling and artificial lift activity picked up too. Halliburton did encounter lower pressure pumping activity in Canada and a fall in drilling fluid activity in the Gulf of Mexico but the company continues to successfully ride the changing market dynamics through excellent execution and management of the controllable factors.
Meanwhile, Halliburton is witnessing broad-based, steady recovery in its international business. The company anticipates its international revenue to grow at a high single-digit rate in 2019, with further improvement next year. Importantly, Halliburton believes it has got the scale and required technology portfolio to take advantage of this growth trend.
Segmental Performance
Operating income from the Completion and Production segment was $470 million, 29.7% below the year-ago level of $669 million. The division’s performance was affected by decline in Latin America stimulation services.
However, the segment operating income bettered our consensus estimate of $430 million. The outperformance was largely the result of strong domestic artificial lift activity, increased cementing job and completion tool sales outside North America, higher stimulation activity in North America and Middle East/Asia, and increased pipeline services throughout Europe/Africa/CIS.
Meanwhile, Drilling and Evaluation unit profit fell from $191 million in the second quarter of 2018 to $145 million in the corresponding period of 2019. The segment income was also below the Zacks Consensus Estimate of $148 million.
The underperformance was on account of lower drilling fluids activity in Latin America and North America, together with decline in software sales. These setbacks were partly offset by stronger project management activity in Middle East/Asia, improved wireline activity globally and increase in North America, Latin America and Europe/Africa/CIS drilling activity.
Balance Sheet
Halliburton’s capital expenditure in the second quarter was $408 million. As of Jun 30, 2019, the Zacks Rank #4 (Sell) company had approximately $1.2 billion in cash/cash equivalents and $10.3 billion in long-term debt, representing a debt-to-capitalization ratio of 52%.
(You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.)
Zacks Rank & Stock Picks
Halliburton currently carries a Zacks Rank #4 (Sell). Meanwhile, investors interested in the oilfield services space could look at some better options like Helix Energy Solutions Group, Inc. (HLX - Free Report) and Oceaneering International, Inc. (OII - Free Report) that sport a Zacks Rank #1 (Strong Buy).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The 2019 Zacks Consensus Estimate for Houston, TX-based Helix Energy Solutions Group is 30 cents, representing some 57.9% earnings per share growth over 2018. Next year’s average forecast is 39 cents pointing to another 27.8% growth.
Oceaneering International has a 100% track of outperforming estimates over the last four quarters at an average rate of 50%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>